Article Information
History
- December 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Julia Brunmair1,
- Andrea Bileck1,2,
- Doreen Schmidl3,
- Gerhard Hagn1,
- Samuel M. Meier-Menches1,2,4,
- Nikolaus Hommer3,
- Andreas Schlatter3,5,
- Christopher Gerner1,2,* and
- Gerhard Garhöfer3,*
- 1Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria
- 2Joint Metabolome Facility, University and Medical University Vienna, Vienna, Austria
- 3Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria
- 4Department of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria
- 5VIROS - Vienna Institute for Research in Ocular Surgery - Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria
- ↵*Correspondence to: Gerhard Garhöfer, Assoc. Prof., M.D., Department of Clinical Pharmacology, Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria, E-mail: Gerhard.garhoefer{at}meduniwien.ac.at, Phone: +43 (0)1 4040029810, Christopher Gerner, Univ.-Prof. Dr., Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38, 1090 Vienna, Austria, E-Mail: christopher.gerner{at}univie.ac.at, Phone: +43 (0) 1 4277 52302
Posted December 02, 2021.
Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients
